These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 28735450)

  • 1. Prescription Drug Price Paradox: Cost Analysis of Canadian Online Pharmacies versus US Medicare Beneficiaries for the Top 100 Drugs.
    Kim SH; Ryu YJ; Cho NE; Kim AE; Chang J
    Clin Drug Investig; 2017 Oct; 37(10):957-963. PubMed ID: 28735450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of costs of Medicare Part D prescriptions dispensed at retail and mail order pharmacies.
    Carroll NV
    J Manag Care Spec Pharm; 2014 Sep; 20(9):959-67. PubMed ID: 25166295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare prescription drug cards: effectiveness for patients with glaucoma.
    Mahadevia AA; Nundy S; Frick KD; Jampel HD
    Arch Ophthalmol; 2006 Aug; 124(8):1175-9. PubMed ID: 16908821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries.
    Lewis JH; Schonlau M; Muñoz JA; Asch SM; Rosen MR; Yang H; Escarce JJ
    N Engl J Med; 2002 Mar; 346(11):830-5. PubMed ID: 11893795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The price may not be right: the value of comparison shopping for prescription drugs.
    Arora S; Sood N; Terp S; Joyce G
    Am J Manag Care; 2017 Jul; 23(7):410-415. PubMed ID: 28817779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Availability of prescription drugs for bipolar disorder at online pharmacies.
    Monteith S; Glenn T; Bauer R; Conell J; Bauer M
    J Affect Disord; 2016 Mar; 193():59-65. PubMed ID: 26766033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of brand-name drug prices between Canadian-based Internet pharmacies and major U.S. drug chain pharmacies.
    Quon BS; Firszt R; Eisenberg MJ
    Ann Intern Med; 2005 Sep; 143(6):397-403. PubMed ID: 16172438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare-approved drug discount cards and prescription drug prices.
    Chisholm MA; Turner JC; Dipiro JT
    Am J Health Syst Pharm; 2005 Jul; 62(14):1482-7. PubMed ID: 15998928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.
    LaVange LM; Silverman HA
    Natl Med Care Util Expend Surv B; 1987 Apr; (12):1-43. PubMed ID: 10313516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Prices of Popular Brand-Name Prescription Drugs in the United States.
    Wineinger NE; Zhang Y; Topol EJ
    JAMA Netw Open; 2019 May; 2(5):e194791. PubMed ID: 31150077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in generic drug prices between the US and Canada.
    Gooi M; Bell CM
    Appl Health Econ Health Policy; 2008; 6(1):19-26. PubMed ID: 18774867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in cash price of the generic medications most prescribed by dermatologists in pharmacies across the United States.
    Alghanem N; Abokwidir M; Fleischer AB; Feldman SR; Alghanem W
    J Dermatolog Treat; 2017 Mar; 28(2):119-128. PubMed ID: 27241622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation.
    Raimond VC; Feldman WB; Rome BN; Kesselheim AS
    Milbank Q; 2021 Mar; 99(1):240-272. PubMed ID: 33751664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage.
    Tseng CW; Brook RH; Keeler E; Steers WN; Mangione CM
    JAMA; 2004 Aug; 292(8):952-60. PubMed ID: 15328327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in estimated Medicare prescription drug plan costs and affordability for beneficiaries living in different states.
    Davis MM; Patel MS; Halasyamani LK
    J Gen Intern Med; 2007 Feb; 22(2):257-63. PubMed ID: 17356996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018.
    Yeung K; Dusetzina SB; Basu A
    JAMA Netw Open; 2021 Jun; 4(6):e2113393. PubMed ID: 34125219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMCP Guide to Pharmaceutical Payment Methods, 2009 Update (Version 2.0).
    Academy of Managed Care Pharmacy
    J Manag Care Pharm; 2009 Aug; 15(6 Suppl A):S3-57, quiz S58-61. PubMed ID: 19678720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation of prescription drug prices in community pharmacies: A national cross-sectional study.
    Larkin J; Moriarty F; McGuinness S; Finucane K; Fitzgerald K; Smith SM; O'Mahony JF
    Res Social Adm Pharm; 2022 Oct; 18(10):3736-3743. PubMed ID: 35618647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.